Sidekick Health, which develops digital therapeutics, raised $55 million in a Series B funding round. The company plans to expand its digital treatments to more chronic health conditions. The round was led by Novator Ventures with participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, and a U.S.-based strategic investor.

The company plans to use the funding to diversify its portfolio and advance the multi-chronic capabilities of its therapeutics platform. It also plans to accelerate its commercial growth in the United States. Sidekick has partnerships with pharmaceutical manufacturers. It also has a digital concierge partnership with the United States health insurer, Anthem.

Sidekick Health operates a scalable digital care platform in partnership with pharmaceutical manufacturers including Pfizer and Bayer, to augment pharmacotherapy, develop integrated combination therapeutics consisting of a drug and a digital therapy. It also creates standalone prescription digital therapeutics.

This was reported by mobihealthnews on May 5, 2022, at https://www.mobihealthnews.com/news/emea/digital-therapeutics-firm-sidekick-lands-55m-series-b-round (accessed May 11, 2022).

Contact information: Sidekick Health, 127 West 30th Street, New York, NY 10001; Email: outcomes@sidekickhealth.com; Website: https://sidekickhealth.com


Tagged As:

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!